KR970704700A - 5--3,4,5,6-테트라히드로 피라미딘-2(1h)-온의 합성 방법 및 이에서의 중간체(processes and intermediates in the synthesis of 5-(3-[exo-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyphenyl)-3,4,5,6-thtrahydropyrimidin-2(1h)-one) - Google Patents
5--3,4,5,6-테트라히드로 피라미딘-2(1h)-온의 합성 방법 및 이에서의 중간체(processes and intermediates in the synthesis of 5-(3-[exo-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyphenyl)-3,4,5,6-thtrahydropyrimidin-2(1h)-one)Info
- Publication number
- KR970704700A KR970704700A KR1019970700752A KR19970700752A KR970704700A KR 970704700 A KR970704700 A KR 970704700A KR 1019970700752 A KR1019970700752 A KR 1019970700752A KR 19970700752 A KR19970700752 A KR 19970700752A KR 970704700 A KR970704700 A KR 970704700A
- Authority
- KR
- South Korea
- Prior art keywords
- intermediates
- synthesis
- thtrahydropyrimidin
- pyramidin
- hept
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 2
- 239000000543 intermediate Substances 0.000 title 2
- 238000003786 synthesis reaction Methods 0.000 title 2
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/10—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/37—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by etherified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Liquid Crystal Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cephalosporin Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019997003696A KR100229840B1 (ko) | 1994-08-05 | 1999-04-28 | 5-(3-[엑소-비시클로[2.2.1]헵트-2-일옥시]-4-메톡시페닐)-3,4,5,6-테트라히드로피리미딘-2(1h)-온의 합성 방법 및 이에서의 중간체 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28657994A | 1994-08-05 | 1994-08-05 | |
US8/286,579 | 1994-08-05 | ||
PCT/IB1995/000319 WO1996004253A1 (en) | 1994-08-05 | 1995-05-04 | Processes and intermediates in the synthesis of 5-(3-[exo-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyphenyl)-3,4,5,6-tetrahydropyrimidin-2(1h)-one |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019997003696A Division KR100229840B1 (ko) | 1994-08-05 | 1999-04-28 | 5-(3-[엑소-비시클로[2.2.1]헵트-2-일옥시]-4-메톡시페닐)-3,4,5,6-테트라히드로피리미딘-2(1h)-온의 합성 방법 및 이에서의 중간체 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR970704700A true KR970704700A (ko) | 1997-09-06 |
KR100234602B1 KR100234602B1 (ko) | 1999-12-15 |
Family
ID=23099248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019970700752A KR100234602B1 (ko) | 1994-08-05 | 1995-05-04 | 5-(3-(엑소-비시클로(2.2.1)헵트-2-일옥시)-4-메톡시페닐)-3,4,5,6-테트라히드로피리미딘-2(1h)-온의합성방법및이에서의중간체 |
Country Status (16)
Country | Link |
---|---|
US (3) | US6022968A (ko) |
EP (1) | EP0775119A1 (ko) |
JP (1) | JP2960965B2 (ko) |
KR (1) | KR100234602B1 (ko) |
CN (2) | CN1431194A (ko) |
AU (1) | AU704116B2 (ko) |
CA (1) | CA2196309C (ko) |
FI (1) | FI970470A0 (ko) |
IL (1) | IL114757A0 (ko) |
MX (1) | MX9700960A (ko) |
MY (1) | MY114675A (ko) |
NO (3) | NO309471B1 (ko) |
NZ (1) | NZ284144A (ko) |
TW (1) | TW427981B (ko) |
WO (1) | WO1996004253A1 (ko) |
ZA (1) | ZA956539B (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6994612B2 (en) * | 2002-02-13 | 2006-02-07 | Micron Technology, Inc. | Methods for conditioning surfaces of polishing pads after chemical-mechanical polishing |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987006576A1 (en) * | 1986-04-29 | 1987-11-05 | Pfizer Inc. | Calcium independent camp phosphodiesterase inhibitor antidepressant |
US5270206A (en) * | 1989-11-13 | 1993-12-14 | Pfizer Inc. | Enzymatic resolution of endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents |
DE69332762T2 (de) * | 1992-12-02 | 2003-08-14 | Pfizer Inc., New York | Cathecoldiether als selektive pde iv hemmungsmittel |
-
1995
- 1995-05-04 MX MX9700960A patent/MX9700960A/es not_active IP Right Cessation
- 1995-05-04 EP EP95915970A patent/EP0775119A1/en not_active Withdrawn
- 1995-05-04 NZ NZ284144A patent/NZ284144A/xx unknown
- 1995-05-04 AU AU22655/95A patent/AU704116B2/en not_active Ceased
- 1995-05-04 JP JP7524231A patent/JP2960965B2/ja not_active Expired - Fee Related
- 1995-05-04 KR KR1019970700752A patent/KR100234602B1/ko not_active IP Right Cessation
- 1995-05-04 US US08/793,084 patent/US6022968A/en not_active Expired - Fee Related
- 1995-05-04 CA CA002196309A patent/CA2196309C/en not_active Expired - Fee Related
- 1995-05-04 WO PCT/IB1995/000319 patent/WO1996004253A1/en not_active Application Discontinuation
- 1995-05-25 TW TW084105309A patent/TW427981B/zh active
- 1995-07-27 IL IL11475795A patent/IL114757A0/xx unknown
- 1995-08-02 MY MYPI95002249A patent/MY114675A/en unknown
- 1995-08-04 ZA ZA9506539A patent/ZA956539B/xx unknown
-
1997
- 1997-02-04 NO NO970497A patent/NO309471B1/no not_active IP Right Cessation
- 1997-02-04 FI FI970470A patent/FI970470A0/fi not_active IP Right Cessation
-
1999
- 1999-10-28 US US09/429,580 patent/US6274733B1/en not_active Expired - Fee Related
-
2000
- 2000-01-26 NO NO20000404A patent/NO310067B1/no not_active IP Right Cessation
- 2000-07-31 NO NO20003899A patent/NO311429B1/no not_active IP Right Cessation
-
2001
- 2001-06-11 US US09/878,830 patent/US6399776B2/en not_active Expired - Fee Related
-
2003
- 2003-01-30 CN CN03104211A patent/CN1431194A/zh active Pending
- 2003-01-30 CN CN03104212A patent/CN1431195A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
NZ284144A (en) | 1999-02-25 |
TW427981B (en) | 2001-04-01 |
JP2960965B2 (ja) | 1999-10-12 |
NO20003899D0 (no) | 2000-07-31 |
NO310067B1 (no) | 2001-05-14 |
NO20003899L (no) | 1997-04-02 |
NO20000404D0 (no) | 2000-01-26 |
US6022968A (en) | 2000-02-08 |
NO309471B1 (no) | 2001-02-05 |
NO970497D0 (no) | 1997-02-04 |
JPH09508643A (ja) | 1997-09-02 |
KR100234602B1 (ko) | 1999-12-15 |
US6399776B2 (en) | 2002-06-04 |
FI970470A (fi) | 1997-02-04 |
US20010041798A1 (en) | 2001-11-15 |
ZA956539B (en) | 1997-02-04 |
CA2196309A1 (en) | 1996-02-15 |
NO20000404L (no) | 1997-04-02 |
NO311429B1 (no) | 2001-11-26 |
MY114675A (en) | 2002-12-31 |
IL114757A0 (en) | 1995-11-27 |
EP0775119A1 (en) | 1997-05-28 |
CA2196309C (en) | 2001-10-16 |
FI970470A0 (fi) | 1997-02-04 |
CN1431195A (zh) | 2003-07-23 |
US6274733B1 (en) | 2001-08-14 |
MX9700960A (es) | 1997-05-31 |
CN1431194A (zh) | 2003-07-23 |
AU2265595A (en) | 1996-03-04 |
NO970497L (no) | 1997-04-02 |
AU704116B2 (en) | 1999-04-15 |
WO1996004253A1 (en) | 1996-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA01008188A (es) | Procesos e intermediarios para la preparacion de 1,3-oxazin-6-onas y uracilos. | |
ZA95269B (en) | Quinazoline-2,4-diones | |
ZA985265B (en) | Carbonates for the delivery of aldehydes and/or ketones | |
HK1018441A1 (en) | Carbamoyl substituted acetals and compositions containing the same | |
KR970704700A (ko) | 5--3,4,5,6-테트라히드로 피라미딘-2(1h)-온의 합성 방법 및 이에서의 중간체(processes and intermediates in the synthesis of 5-(3-[exo-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyphenyl)-3,4,5,6-thtrahydropyrimidin-2(1h)-one) | |
BR9704104B1 (pt) | levedura de padeiro. | |
Bergantino et al. | An econometric analysis of the decision to flag out | |
HK1032055A1 (en) | Process and intermediates for the preparation of atriazoline herbicide. | |
EP0965634A4 (en) | NEW PRIMER AND USE | |
NO992501L (no) | Fremgangsmåte ved fremstilling av 2-amin-2-imidazolin-, guanidin- og 2-amin-3,4,5,6-tetrahydropyrimidin-derivater | |
AU3697297A (en) | Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetics and pharmaceuticals | |
Kuhn | The relationship between smoking behaviour and psychosocial adjustment following acute myocardial infarction. | |
ZA9710265B (en) | Substituted Tetrahydro-1,3,5-Triazin-2[1H]-thiones as anti-atherosclerotic agents. | |
GB9919041D0 (en) | Use of cyanines,isocyaninines and pseudoisocyanines as diuretics | |
EP0666287A3 (de) | Basische Farbstoffe auf Basis von Amiden der 1-Hydroxy-6-aminonaphtalin-3-sulfonsäure sowie deren Zwischenprodukte. | |
ZA978233B (en) | The use of protein as anti-retroviral agents. | |
AU2306799A (en) | Intermediates and process for the syntheses of 17-unsubstituted 16.beta.-aryloxy4-azasteroids | |
TR200000952A3 (tr) | 1,1-dioksopenisilanoiloksimetil 6-[D-alfa-(benzilidenamino-fenilasetamido)] penisilanat ve benzerlerinin sentezi. Sultamisilin sentezinde elverisli yeni ara maddeler. | |
MA24596A1 (fr) | Polyalkylenemines alcoxyle compatible avec l'agent de blanchiment. | |
Dankel | Proceedings of FLAIRS-10 | |
HK1028893A1 (en) | 2-Aminopropane-1,3-diol compounds, medicinal use thereof, and intermediates in synthesizing the same. | |
Powell et al. | 8. Evaluation of charter school effectiveness.(1997) | |
ZA9710553B (en) | Urea and thiourea derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists. | |
ZA978838B (en) | Heterocycle-fused pyrimidinone derivative and herbicidal composition. | |
ZA978759B (en) | 4,4-Disubstituted-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
A107 | Divisional application of patent | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20020528 Year of fee payment: 4 |
|
LAPS | Lapse due to unpaid annual fee |